Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Gouyer, Valérie ^a,b   Dubuquoy, Laurent ^a   Robbe Masselot, Catherine ^c   Neut, Christel ^a   Singer, Elisabeth ^a   Plet, Ségolène ^a   Geboes, Karel ^d   Desreumaux, Pierre ^a,b   Gottrand, Frédéric ^a,b   Desseyn, Jean Luc ^a  

^a UNIVERSITÉ DE LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; MICROSPHERE; MUC1 PROTEIN, MOUSE; MUC2 PROTEIN, MOUSE; MUC3 PROTEIN, MOUSE; MUC6 PROTEIN, MOUSE; MUCIN 1; MUCIN 2; MUCIN 3; MUCIN 6;

ANIMAL; C57BL MOUSE; CHEMISTRY; CITROBACTER RODENTIUM; CYTOLOGY; EPITHELIUM CELL; ESCHERICHIA COLI; GENETICS; GLYCOSYLATION; GOBLET CELL; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE; INTESTINE FLORA; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; MOUSE; MUCUS; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TIGHT JUNCTION; TRANSGENIC MOUSE;

ANIMALS; CITROBACTER RODENTIUM; CYSTEINE; EPITHELIAL CELLS; ESCHERICHIA COLI; GASTROINTESTINAL MICROBIOME; GLYCOSYLATION; GOBLET CELLS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINES; LACTOBACILLUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSPHERES; MUCIN-1; MUCIN-2; MUCIN-3; MUCIN-6; MUCUS; PROTEIN STRUCTURE, TERTIARY; TIGHT JUNCTIONS;

EID: 84929377883     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09577     Document Type: Article

References (78)

1. Pullan, R. D. et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 35, 353 (1994).
2. Schultsz, C. et al. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 117, 1089 (1999).
3. Bergstrom, K. S. et al. Muc2 Protects against Lethal Infectious Colitis by Disassociating Pathogenic and Commensal Bacteria from the Colonic Mucosa. PLoS. Pathog. 6, e1000902 (2010).
4. Johansson, M. E. et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63, 281 (2013).
5. Manichanh, C. et al. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9, 599 (2012).
6. Hajishengallis, G., Darveau, R. P. & Curtis, M. A. The keystone-pathogen hypothesis. Nat. Rev. Microbiol. 10, 717 (2012).
7. Swidsinski, A. et al. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 56, 343 (2007).
8. Theodoratou, E. et al. The role of glycosylation in IBD. Nat. Rev. Gastroenterol. Hepatol. 11, 588 (2014).
9. Lang, T., Hansson, G. C. & Samuelsson, T. Gel-forming mucins appeared early in metazoan evolution. Proc. Natl. Acad. Sci. USA 104, 16209 (2007).
10. Thornton, D. J., Rousseau, K. & McGuckin, M. A. Structure and function of the polymeric mucins in airways mucus. Annu. Rev. Physiol 70, 459 (2008).
11. Gouyer, V., Gottrand, F. & Desseyn, J. L. The extraordinarily complex but highly structured organization of intestinal mucus-gel unveiled in multicolor images. PLoS One 6, e18761 (2011).
12. Godl, K. et al. The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragment. J. Biol. Chem. 277, 47248 (2002).
13. Brockhausen, I. Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1473, 67 (1999).
14. Johansson, M. E. & Hansson, G. C. Microbiology. Keeping bacteria at a distance. Science 334, 182 (2011).
15. Johansson, M. E., Larsson, J. M. & Hansson, G. C. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. USA 108 Suppl 1, 4659 (2011).
16. Desseyn, J. L. Mucin CYS domains are ancient and highly conserved modules that evolved in concert. Mol. Phylogenet. Evol. 52, 284 (2009).
17. Bansil, R. & Turner, B. S. Mucin structure, aggregation, physiological functions and biomedical applications. Curr. Opin. in Colloid & Interface Science 11, 164 (2006).
18. Brunelli, R. et al. Globular structure of human ovulatory cervical mucus. FASEB J 21, 3872 (2007).
19. Cao, X. et al. pH-dependent conformational change of gastric mucin leads to sol-gel transition. Biophys. J 76, 1250 (1999).
20. Hong, Z. et al. Atomic force microscopy reveals aggregation of gastric mucin at low pH. Biomacromolecules. 6, 3458 (2005).
21. Round, A. N. et al. Heterogeneity and persistence length in human ocular mucins. Biophys. J 83, 1661 (2002).
22. Maleki, A. et al. Effect of pH on the association behavior in aqueous solutions of pig gastric mucin. Carbohydr. Res. 343, 328 (2008).
23. Ambort, D. et al. Function of the CysD domain of the gel-forming MUC2 mucin. Biochem. J. 436, 61 (2011).
24. Madsen, J. et al. Tissue localization of human trefoil factors 1, 2, and 3. J. Histochem. Cytochem. 55, 505 (2007).
25. Toribara, N. W. et al. Human gastric mucin. Identification of a unique species by expression cloning. J. Biol. Chem. 268, 5879 (1993).
26. Gouyer, V. et al. The characterization of the first anti-mouse Muc6 antibody shows an increased expression of the mucin in pancreatic tissue of Cftr-knockout mice. Histochem. Cell Biol. 133, 517 (2010).
27. Desseyn, J. L., Tetaert, D. & Gouyer, V. Architecture of the large membrane-bound mucins. Gene 410, 215 (2008).
28. Moniaux, N. et al. Characterization of human mucin MUC17. Complete coding sequence and organization. J. Biol. Chem. 281, 23676 (2006).
29. Bry, L. et al. A model of host-microbial interactions in an open mammalian ecosystem. Science 273, 1380 (1996).
30. Hooper, L. V. et al. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc. Natl. Acad. Sci. USA 96, 9833 (1999).
31. Tomita, M. et al. Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes. Biochem. J. 311, 293 (1995).
32. Melgar, S., Karlsson, A. & Michaelsson, E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am. J. Physiol Gastrointest. Liver Physiol 288, G1328 (2005).
33. Drouet, M. et al. AIEC colonization and pathogenicity: influence of previous antibiotic treatment and preexisting inflammation. Inflamm. Bowel. Dis. 18,1923 (2012).
34. Darfeuille-Michaud, A. et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115, 1405 (1998).
35. Darfeuille-Michaud, A. et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412 (2004).
36. Johansson, M. E. et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 105, 15064 (2008).
37. Johansson, M. E. et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63, 281 (2014).
38. Desseyn, J. L. et al. Evolutionary history of the 11p15 human mucin gene family. J. Mol. Evol. 46, 102 (1998).
39. Spada, F. et al. Molecular patterning of the oikoplastic epithelium of the larvacean tunicate Oikopleura dioica. J Biol. Chem. 276, 20624 (2001).
40. Atuma, C. et al. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am. J. Physiol Gastrointest. Liver Physiol 280, G922 (2001).
41. Ota, H. & Katsuyama, T. Alternating laminated array of two types of mucin in the human gastric surface mucous layer. Histochem. J. 24, 86 (1992).
42. Bel, S. et al. Loss of TMF/ARA160 protein renders colonic mucus refractory to bacterial colonization and diminishes intestinal susceptibility to acute colitis. J. Biol. Chem. 287, 25631 (2012).
43. Bel, S. et al. Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF-/- mice. Proc. Natl. Acad. Sci. USA 111, 4964 (2014).
44. von Schillde, M. A. et al. Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host. Microbe 11, 387 (2012).
45. Sansonetti, P. J. War and peace at mucosal surfaces. Nat. Rev. Immunol. 4, 953 (2004).
46. Hooper, L. V. et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881 (2001).
47. Patsos, G. & Corfield, A. Management of the human mucosal defensive barrier: evidence for glycan legislation. Biol. Chem. 390, 581 (2009).
48. Salyers, A. A. & Pajeau, M. Competitiveness of different polysaccharide utilization mutants of Bacteroides thetaiotaomicron in the intestinal tracts of germfree mice. Appl. Environ. Microbiol. 55, 2572 (1989).
49. Becker, D. J. & Lowe, J. B. Fucose: biosynthesis and biological function in mammals. Glycobiology 13, 41R (2003).
50. Gutierrez-Castrellon, P. et al. Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial. Pediatrics 133, e904 (2014).
51. Oliva, S. et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment. Pharmacol. Ther. 35, 327 (2012).
52. Liévin-Le Moal, V. & Servin, A. L. Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal antiinfectious biotherapeutic agents. Clin Microbiol Rev. 27, 167 (2014).
53. Nardi, R. M. et al. Purification and molecular characterization of antibacterial compounds produced by Lactobacillus murinus strain L1. J. Appl. Microbiol. 99, 649 (2005).
54. Van Tassell, M. L. & Miller, M. J. Lactobacillus adhesion to mucus. Nutrients 3, 613 (2011).
55. Etzold, S. et al. Structural basis for adaptation of lactobacilli to gastrointestinal mucus. Environ. Microbiol. 16, 888 (2014).
56. Uchida, H. et al. Lactic acid bacteria (LAB) bind to human B- or H-antigens expressed on intestinal mucosa. Biosci. Biotechnol. Biochem. 70, 3073 (2006).
57. Uchida, H. et al. Lactobacilli binding human A-antigen expressed in intestinal mucosa. Res. Microbiol. 157, 659 (2006).
58. Roos, S. & Jonsson, H. A high-molecular-mass cell-surface protein from Lactobacillus reuteri 1063 adheres to mucus components. Microbiology 148, 433 (2002).
59. Nanda Kumar, N. S. et al. Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate. J. Gastroenterol. Hepatol. 23, 1834 (2008).
60. Mackos, A. R. et al. Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infection. Infect. Immun. 81, 3253 (2013).
61. Ingrassia, I., Leplingard, A. & rfeuille-Michaud, A. Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells. Appl. Environ. Microbiol. 71, 2880 (2005).
62. Ho, N. K. et al. Immune signalling responses in intestinal epithelial cells exposed to pathogenic Escherichia coli and lactic acid-producing probiotics. Benef. Microbes. 4, 195 (2013).
63. Itoh, H., Inoue, N. & Podolsky, D. K. Goblet-cell-specific transcription of mouse intestinal trefoil factor gene results from collaboration of complex series of positive and negative regulatory elements. Biochem. J. 341, 461 (1999).
64. Heim, R., Cubitt, A. B. & Tsien, R. Y. Improved green fluorescence. Nature 373, 663 (1995).
65. Desseyn, J. L. et al. Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains resulting in a super-repeat. Structural evidence for a 11p15.5 gene family. J. Biol. Chem. 272, 3168 (1997).
66. Rousseau, K. et al. New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7. Hybrid. Hybridomics. 22, 293 (2003).
67. Wickstrom, C. et al. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem. J. 334, 685 (1998).
68. Desseyn, J. L. et al. Genomic organization of the 3′ region of the human mucin gene MUC5B. J. Biol. Chem. 272, 16873 (1997).
69. Sambrook, J., Fritsch, E. F. & Maniatis, T. [Molecular cloning: a laboratory manual], [Cold Spring Harbor Lab. Press, Plainview, NY (ed.)] (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, USA, 1989).
70. Gordon, J. W. Production of transgenic mice. Methods Enzymol. 225, 747 (1993).
71. Wu, Q. et al. A simple, rapid method for isolation of high quality genomic DNA from animal tissues. Nucleic Acids Res. 23, 5087 (1995).
72. Rossez, Y. et al. Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori. Glycobiology 22, 1193 (2012).
73. Montreuil, J. et al. [Carbohydrate Analysis: A Practical Approach]: [Chaplin, M. F. & Kennedy, J. F. (ed.)], [143-204] (IRL Press, Oxford, 1986).
74. Tetaert, D. et al. Dietary n-3 fatty acids have suppressive effects on mucin upregulation in mice infected with Pseudomonas aeruginosa. Respir. Res. 8, 39 (2007).
75. Pineton de Chambrun, G. et al. Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice. Mucosal. Immunol. 7, 589 (2014).
76. Dieleman, L. A. et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 114, 385 (1998).
77. Han, W. et al. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm. Bowel. Dis. 12, 1044 (2006).
78. Borenshtein, D. et al. Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect. Immun. 75, 3271 (2007).